Critical chip firm ASML posts profit beat but sales miss expectations with 22% drop
Related Articles
-
Abbott beats quarterly profit estimates on strong medical device sales
Abbott Laboratories beat Wall Street estimates for quarterly profit on Wednesday and raised the lower end of its annual forecast on robust sales of its medical devices, including glucose-monitoring products. Sales of Abbott's medical devices have been strengthened in recent quarters due to a resurgence in the demand for joint replacements as well as other surgeries delayed during the COVID-19 pandemic. Industry bellwether and rival Johnson & Johnson said on Tuesday it continues to expect...
-
Google parent announces first-ever dividend; beats on sales, profit; shares soar
Alphabet announced its first-ever dividend on Thursday and a $70 billion stock buyback, cheering investors who sent the stock surging nearly 16% after the bell. The Google parent is returning capital while spending billions of dollars on data centers to catch up with rivals on generative artificial intelligence. The dividend will be 20 cents per share. Just three months ago, Alphabet's Big Tech rival, Meta Platforms, announced its own first-ever dividend, a move that lifted the social media...
-
TSMC beats first-quarter revenue and profit expectations on strong AI chip demand
TSMC is the world's largest producer of advanced processors and counts companies such as Nvidia and Apple as its clients.